Medicine and Dentistry
Blood Stasis
100%
Von Willebrand Disease
81%
Von Willebrand Factor
73%
Laboratory Test
52%
Thrombosis
49%
Diagnosis
46%
Diseases
36%
COVID-19
29%
Thrombocyte Function
27%
Platelet
23%
Lupus Anticoagulant
21%
D-Dimer
21%
Antithrombotic
21%
Heparin
20%
Prothrombin Time
19%
Venous Thromboembolism
18%
Bleeding
18%
Partial Thromboplastin Time
17%
PFA-100
17%
Bleeding Disorder
17%
Thrombophilia
17%
Blood Clotting Factor
16%
Direct Oral Anticoagulant
15%
Antiphospholipid Antibody
15%
Hematology
15%
Blood Clotting Factor 8
13%
Heparin-Induced Thrombocytopenia
13%
Laboratory Assessment
13%
Diagnostic Error
12%
Fibrinogen
11%
Haemophilia
11%
Hemostat
11%
Thrombotic Thrombocytopenic Purpura
10%
Blood Clotting Test
10%
Clinician
10%
Coagulation Testing
10%
Antiphospholipid Syndrome
10%
Vitamin K Antagonist
10%
In Vitro
10%
Pathologist
9%
Von Willebrand Factor Cleaving Proteinase
9%
Anticoagulant Therapy
9%
Anticoagulant
9%
Thrombocyte Aggregation
9%
Immunoassay
9%
Laboratory Diagnosis
9%
Ristocetin
8%
Protein C
8%
Phlebothrombosis
8%
False Positive Result
8%
Keyphrases
Von Willebrand Disease
88%
Von Willebrand Factor
81%
Hemostasis
56%
Laboratory Testing
43%
Thrombosis
39%
Activated Partial Thromboplastin Time (aPTT)
26%
COVID-19
24%
Hemostasis Testing
22%
Lupus Anticoagulant
21%
Antiphospholipid Antibodies
20%
Heparin
19%
Hemostasis Laboratory
18%
Heparin-induced Thrombocytopenia
18%
Preanalytical Phase
17%
Type 2B Von Willebrand Disease
17%
D-dimer
16%
Platelets
15%
PFA-100
15%
Venous Thromboembolism
14%
Anticoagulants
14%
Direct Oral Anticoagulants
14%
External Quality Assurance
14%
Laboratory Diagnosis
14%
Quality Assurance Program
13%
Bleeding
13%
Thrombophilia
13%
Antiphospholipid Syndrome
12%
Australia
12%
Prothrombin Time
12%
Anticardiolipin Antibodies
11%
Fibrinogen
11%
Laboratory Assessment
11%
Multi-laboratory
11%
Von Willebrand Factor Antigen
11%
Coagulation Testing
11%
International Normalized Ratio
10%
Antibody Test
10%
Platelet Function
10%
Laboratory Identification
10%
Coagulation
10%
Internal Quality Control
9%
Platelet Aggregation
9%
ADAMTS13
9%
Royal College of Pathologists
9%
Collagen Binding Assay
9%
Collagen Binding
9%
Hematology
9%
Factor Inhibitors
9%
Hemophilia
9%
Venous Thrombosis
9%
Pharmacology, Toxicology and Pharmaceutical Science
Von Willebrand Factor
67%
Von Willebrand Disease
60%
Disease
46%
Blood Stasis
46%
Thrombosis
29%
Anticoagulant Agent
27%
Heparin
23%
Thromboplastin
22%
Coronavirinae
19%
Prothrombin
17%
Blood Clotting Factor 8
15%
Direct Oral Anticoagulant
15%
Blood Clotting Factor
14%
Lupus Anticoagulant
14%
Bleeding
14%
Venous Thromboembolism
11%
Thrombotic Thrombocytopenic Purpura
10%
Ristocetin
9%
Bleeding Disorder
9%
Von Willebrand Factor Cleaving Proteinase
9%
Thrombin
9%
Heparin Induced Thrombocytopenia
9%
D Dimer
9%
Desmopressin
9%
Rivaroxaban
8%
Fibrinogen
8%
Vein Thrombosis
7%
Antivitamin K
7%
Haemophilia
6%
Syndrome
6%
Thrombophilia
6%
Haemophilia A
6%
Dabigatran
6%
Warfarin
6%
Hemostatic Agent
6%
Enzyme-Linked Immunosorbent Assay
6%
Cardiovascular Disease
6%
Apixaban
5%
Polymer
5%
Antiphospholipid Antibody
5%
